Theradaptive — Department of Defense SBIR Phase II: DHA17-009
Theradaptive — SBIR Phase II award from Department of Defense.
- Amount
- $1,149,031
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHA17-009
- Solicitation
- 17.1
- NAICS
- —
- Place of performance
- MD
- Period
- 2020-06-15 → 2022-10-20
Description
Our proposal develops an osteochondral repair platform that is conformable to a wide variety of injury geometries without the need for preoperative customization. Further this platform does not rely on any autologous tissue and is amenable to scalable man